Roivant Sciences (ROIV) Total Non-Current Liabilities (2021 - 2026)

Roivant Sciences (ROIV) has 6 years of Total Non-Current Liabilities data on file, last reported at $11.9 million in Q1 2026.

• Quarterly Total Non-Current Liabilities fell 35.5% year-over-year to $11.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.9 million (down 35.5% YoY) and the FY2026 annual result came in at $11.9 million, down 35.5% from the prior year.
• Total Non-Current Liabilities fell to $11.9 million in Q1 2026, from $4.0 billion in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $4.0 billion in Q4 2025 to a low of $11.9 million in Q1 2026.
• A 5-year average of $748.9 million and a median of $668.6 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2024 — Total Non-Current Liabilities plunged 97.99% — and 2025, when it jumped 225.93%.
• Tracing ROIV's Total Non-Current Liabilities over 5 years: stood at $754.3 million in 2022, then fell by 11.36% to $668.6 million in 2023, then jumped by 85.04% to $1.2 billion in 2024, then jumped by 225.93% to $4.0 billion in 2025, then plunged by 99.71% to $11.9 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $11.9 million (Q1 2026), $4.0 billion (Q4 2025), and $257.0 million (Q3 2025), per Business Quant data.